Furthermore, survival analysis specifically highlighted that KDM4B expression consistently showed a negative correlation with overall survival in both colorectal adenocarcinoma (COAD) and skin cutaneous melanoma (SKCM) (Figures 7B and S12B). This evidence concerns the gene KDM4B and colon adenocarcinoma.